Home Cart 0 Sign in  

[ CAS No. 165377-44-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 165377-44-6
Chemical Structure| 165377-44-6
Structure of 165377-44-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 165377-44-6 ]

Related Doc. of [ 165377-44-6 ]

Alternatived Products of [ 165377-44-6 ]

Product Details of [ 165377-44-6 ]

CAS No. :165377-44-6 MDL No. :MFCD00939308
Formula : C23H34Cl2N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :XWOXAKBQEMQMFH-UHFFFAOYSA-N
M.W : 441.43 Pubchem ID :9954941
Synonyms :
SA4503 dihydrochloride;AGY94806 dihydrochloride;Cutamesine;AGY 94806;SA 4503;Cutamesine dihydrochloride

Calculated chemistry of [ 165377-44-6 ]

Physicochemical Properties

Num. heavy atoms : 29
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.48
Num. rotatable bonds : 9
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 132.77
TPSA : 24.94 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.11 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 5.47
Log Po/w (WLOGP) : 4.34
Log Po/w (MLOGP) : 3.35
Log Po/w (SILICOS-IT) : 4.54
Consensus Log Po/w : 3.54

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.74
Solubility : 0.000812 mg/ml ; 0.00000184 mol/l
Class : Moderately soluble
Log S (Ali) : -5.75
Solubility : 0.000783 mg/ml ; 0.00000177 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -6.92
Solubility : 0.0000528 mg/ml ; 0.00000012 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 2.87

Safety of [ 165377-44-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 165377-44-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 165377-44-6 ]

[ 165377-44-6 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 2038-57-5 ]
  • [ 100915-88-6 ]
  • [ 165377-44-6 ]
YieldReaction ConditionsOperation in experiment
0.68 g (77%) With hydrogenchloride; sodium iodide; potassium carbonate In <i>N</i>-methyl-acetamide; ethanol; water 1 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride (compound No. 1-1) STR9 Example 1 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride (compound No. 1-1) STR9 To a solution of N,N-bis(2-chloroethyl)-2-(3,4-dimethoxyphenyl)ethylamine hydrochloride (reference compound No. 2-1, 0.69 g) and 3-phenylpropylamine (0.41 g) in dimethylformamide (20 ml) were added potassium carbonate (0.83 g) and sodium iodide (0.90 g). The mixture was stirred at 70° C. for 2 hours. To the reaction mixture, water was added, and the whole was extracted with ethyl acetate. The organic layer was washed with water and a saturated sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated in vacuo. The oily residue was dissolved in ethanol, 6N hydrochloric acid (2 ml) was added thereto, and the solution was concentrated in vacuo to give 0.68 g (77%) of the titled compound (compound No. 1-1). mp 258°-260° C. (decomp.) IR (KBr, cm-1) 3977, 2355, 1518, 1265, 1140, 1028, 754, 704
  • 2
  • [ 165377-44-6 ]
  • [ 165377-43-5 ]
YieldReaction ConditionsOperation in experiment
With sodium hydroxide In tetrahydrofuran; water 15 To a suspension of l-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3- phenylpropyl)piperazine dihydrochloride (1.06 g, 2.40 mmol) in THF (5 niL) is added a solution of sodium hydroxide (IN, 6 mL). To the resulting solution is added ethyl acetate and brine. The organic layer is separated, filtered through silica gel, dried over anhydrous sodium sulfate, concentrated, and dried to give 0.829 g of l-[2-(3,4- dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine as a light brown solid.To a solution of l-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (0.829 g, 2.25 mmol) in dichloromethane (DCM, 20 mL) is added boron tribromide (BBr3) drop wise at -78 °C under nitrogen. After the addition had been completed, the reaction solution is slowly warmed to 0 °C, stirred for 5 h and then cooled to -10 °C. To the cooled reaction mixture is added water cautiously. The resulting mixture is neutralised with sodium bicarbonate at ambient temperature and extracted with ethyl acetate/THF. The organic layer is separated, filtered through silica gel, dried over sodium sulfate, concentrated, and dried in a vacuum oven. . The residue is then purified by column chromatography eluting with dichloromethane-methanol to afford 0.57 g of 1- [2-(3,4-dihydroxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine . This material is then dissolved in ethanol and treated with 6 N hydrogen chloride aqueous solution to pH=3. The resultant crystals are filtered, washed with cold ethanol, and dried to give 212 mg of the title compound (25% from l-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3- phenylpropyl)piperazine dihydrochloride ). 1H-NMR (400MHz, DMSO-d6): δ 2.02 (b, 2H), 2.64 (t, 2H), 2.86 (b, 2H), 3.1-3.8 (m, 12), 6.51 (d, IH), 6.67 (m, 2H), 7.11-7.33 (m, 5H), 8.84 (b, 2H), 11.6 (b, 2H).
Same Skeleton Products
Historical Records